×
For best experience we recommend to activate Javascript in your browser.
CREB3L1 antibody (C-Term)
This anti-CREB3L1 antibody is a Rabbit Polyclonal antibody detecting CREB3L1 in WB, ELISA and IHC. Suitable for Human.
Quick Overview for CREB3L1 antibody (C-Term) (ABIN2317449)
Target
See all CREB3L1 Antibodies
CREB3L1
(CAMP Responsive Element Binding Protein 3-Like 1 (CREB3L1))
Reactivity
All reactivities for CREB3L1 antibodies
Human
Host
All hosts for CREB3L1 antibodies
Rabbit
Clonality
All clonalities for CREB3L1 antibodies
Polyclonal
Conjugate
All conjugates for CREB3L1 antibodies
This CREB3L1 antibody is un-conjugated
Application
All applications for CREB3L1 antibodies
Western Blotting (WB), ELISA, Immunohistochemistry (IHC)
Product Details anti-CREB3L1 Antibody
(hide)
Binding Specificity
All epitopes for CREB3L1 antibodies
C-Term
Cross-Reactivity
Human
Cross-Reactivity (Details)
Calculated cross reactivity: Hu
Characteristics
OASIS, CT (Cyclic AMP-responsive Element-binding Protein 3-like Protein 1, cAMP-responsive Element-binding Protein 3-like Protein 1, Old Astrocyte Specifically-induced Substance, Processed Cyclic AMP-responsive Element-binding Protein 3-like Protein 1, CREB3L1, PSEC0238)
Purification
Purified by Protein G affinity chromatography.
Immunogen
Synthetic peptide selected from the C-terminal region of human OASIS (KLH).
Isotype
IgG
Alternatives
(show)
Application Details
(hide)
Application Notes
Optimal working conditions should be determined by the investigator.
Restrictions
For Research Use only
Handling
(hide)
Format
Liquid
Buffer
Supplied as a liquid in PBS, 0.09 % sodium azide.
Preservative
Sodium azide
Precaution of Use
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage
-20 °C
Storage Comment
-20°C
Target Details for CREB3L1
(hide)
Target
CREB3L1
(CAMP Responsive Element Binding Protein 3-Like 1 (CREB3L1))
Alternative Name
OASIS
NCBI Accession
NP_443086
Pathways
Thyroid Hormone Synthesis , Chromatin Binding
Recently viewed
(hide)
Chat with us , powered by LiveChat